Quantcast

Latest Noven Pharmaceuticals Inc. Stories

2014-03-25 08:31:12

MIAMI and NEW YORK, March 25, 2014 /PRNewswire/ -- Noven Pharmaceuticals, Inc. today announced the U.S. Patent and Trademark Office has issued U.S. Patent No. 8,658,663, entitled "Method Of Treating Thermoregulatory Dysfunction With Paroxetine." This method of use patent covers the company's Brisdelle(®) (paroxetine) capsules, 7.5 mg, for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause, commonly referred to as hot flashes....

2014-01-13 08:29:50

Co-Promotion to Extend Physician Awareness of the First and Only FDA-Approved, Non-Hormonal Treatment for Moderate to Severe Menopausal Hot Flashes MIAMI and NEW YORK, Jan. 13, 2014 /PRNewswire/ -- Noven Pharmaceuticals, Inc. today announced that it has entered into an agreement with Shionogi Inc. to co-promote Brisdelle(TM) (paroxetine) capsules, 7.5 mg. The agreement will help extend physician awareness of the first and only FDA-approved, non-hormonal treatment for moderate to severe...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related